Harel Insurance Investments & Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560M | Buy |
|
|||||
|
2025
Q1 | $339M | Buy |
|
|||||
|
2024
Q4 | $246K | Sell |
|
|||||
|
2024
Q3 | $355K | Buy |
|
|||||
|
2024
Q2 | $312K | Sell |
|
|||||
|
2024
Q1 | $363K | Sell |
|
|||||
|
2023
Q4 | $298M | Buy |
|
|||||
|
2023
Q3 | $283M | Buy |
|
|||||
|
2023
Q2 | $114K | Sell |
|
|||||
|
2023
Q1 | $206M | Buy |
|
|||||
|
2022
Q4 | $138M | Buy |
|
|||||
|
2022
Q3 | $114M | Buy |
|
|||||
|
2022
Q2 | $86.1M | Buy |
|
|||||
|
2022
Q1 | $98.4M | Buy |
|
|||||
|
2021
Q4 | $79.6M | Sell |
|
|||||
|
2021
Q3 | $97.8M | Buy |
|
|||||
|
2021
Q2 | $98.6M | Sell |
|
|||||
|
2021
Q1 | $116M | Buy |
|
|||||
|
2020
Q4 | $89.9M | Buy |
|
|||||
|
2020
Q3 | $72.9M | Buy |
|
|||||
|
2020
Q2 | $93.9M | Buy |
|
|||||
|
2020
Q1 | $58.6M | Buy |
|
|||||
|
2019
Q4 | $52.4M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $49.4M | Buy |
|
|||||
|
2019
Q1 | $83.4M | Sell |
|
|||||
|
2018
Q4 | $88.1M | Buy |
|
|||||
|
2018
Q3 | $61.6M | Buy |
|
|||||
|
2018
Q2 | $43.7M | Sell |
|
|||||
|
2018
Q1 | $35.6M | Sell |
|
|||||
|
2017
Q4 | $45.9M | Buy |
|
|||||
|
2017
Q3 | $44.7M | Buy |
|
|||||
|
2017
Q2 | $47.5M | Sell |
|
|||||
|
2017
Q1 | $46.1M | Buy |
|
|||||
|
2016
Q4 | $13K | Sell |
|
|||||
|
2016
Q3 | $25.3M | Sell |
|
|||||
|
2016
Q2 | $61.4M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $62.5M | Buy |
|